SLC7A11 and lung adenocarcinoma: METTL3 can mediate m6A modification of SLC7A11 mRNA (Fig. 2B), which stabilizes SLC7A11 mRNA and promotes its translation, thus enhancing ferroptosis resistance of lung adenocarcinoma [81] and hepatoblastoma [82].